As filed with the Securities and Exchange Commission on February 13, 2023

Registration No. 333-                 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM S-8

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

PLURI INC.

(Exact name of registrant as specified in its charter)

 

Nevada   98-0351734
(State or other jurisdiction of
incorporation or organization)		   (I.R.S. Employer
Identification No.)

 

MATAM Advanced Technology Park,
Building No. 5, Haifa, Israel		   3508409
(Address of Principal Executive Offices)   (Zip Code)

   

Pluri Inc. 2016 Equity Compensation Plan

(Full title of the plan)

 

Nevada Agency and Transfer Company

50 West Liberty Street, Suite 880

Reno, NV 89501

(Name and address of agent for service)

 

(775) 322-0626

(Telephone number, including area code, of agent for service)

 

Copy to:

 

Oded Har-Even

Howard E. Berkenblit

Ron Ben-Bassat

Sullivan & Worcester LLP

1633 Broadway

New York, NY 10019

Tel: (212) 660-3000

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer  ☐ Accelerated filer  ☐
Non-accelerated filer  ☒ Smaller reporting company  ☒
  Emerging growth company  ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

  

 

 

 

 

 

EXPLANATORY NOTE

 

On June 29, 2016, Pluri Inc., or the Company, filed a Registration Statement on Form S-8 (File No. 333-212299), or the Original Registration Statement, with the Securities and Exchange Commission, or the Commission, to register an aggregate of 2,614,197 common shares of the Company, or the Common Shares, that may be issued pursuant to the Company’s 2016 Equity Compensation Plan, or the 2016 Plan.

 

On May 8, 2017, the Company filed a Registration Statement on Form S-8 (File No. 333-217770), or the Second Registration Statement, with the Commission to register an additional 252,700 Common Shares that may be issued pursuant to the 2016 Plan.

 

On February 6, 2018, the Company filed a Registration Statement on Form S-8 (File No. 333-222888), or the Third Registration Statement, with the Commission to register an additional 345,000 Common Shares that may be issued pursuant to the 2016 Plan.

 

On February 6, 2019, the Company filed a Registration Statement on Form S-8 (File No. 333-229535), or the Fourth Registration Statement, with the Commission to register an additional 345,000 Common Shares that may be issued pursuant to the 2016 Plan.

 

On September 9, 2020, the Company filed a Registration Statement on Form S-8 (File No. 333-248686), or the Fifth Registration Statement, with the Commission to register an additional 150,000 Common Shares that may be issued pursuant to the 2016 Plan.

 

Pursuant to the 2016 Plan, the number of Common Shares made available under the 2016 Plan shall not exceed 2.75% of the number of Common Shares issued and outstanding on a fully diluted basis on the immediately preceding December 31.

 

The Company is filing this Registration Statement on Form S-8 to register an additional 1,800,000 Common Shares which may be issued in connection with securities awards which may hereafter be granted under the 2016 Plan.

 

Pursuant to General Instruction E to Form S-8, the contents of the Original Registration Statement, the Second Registration Statement, the Third Registration Statement, the Fourth Registration Statement and the Fifth Registration Statement, or collectively, the Prior Registration Statements, are incorporated herein by reference, except for Item 3 and Item 8 of Part II of the Prior Registration Statements, which are being updated by this registration statement.

 

 

 

 

PART II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 3.  Incorporation of Documents by Reference. 

 

The following additional documents, which have been filed by the Company with the Commission under the Securities Exchange Act of 1934, as amended, or the Exchange Act, are incorporated by reference in and made a part of this registration statement, as of their respective dates:

 

(a) Our Annual Report on Form 10-K for the year ended June 30, 2022 filed with the SEC on September 21, 2022;

 

(b) Our Quarterly Reports on Form 10-Q for the quarters ended September 30, 2022 and December 31, 2022, as filed with the SEC on November 10, 2022, and February 13, 2023, respectively;

 

(c) Our Current Reports on Form 8-K filed with the SEC on July 13, 2022, July 25, 2022, September 29, 2022, October 13, 2022, December 19, 2022, December 28, 2022, January 24, 2023 and February 6, 2023; and

 

(d) The description of the Company’s Common Stock contained in the Registration Statement on Form 8-A filed with the Commission on December 10, 2007, under the Exchange Act, including any amendment or report filed or to be filed for the purpose of updating such description.

 

In addition to the foregoing, all documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequently filed by the Company prior to the filing of a post-effective amendment which indicates that all securities offered hereunder have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be part hereof from the date of filing of such documents and reports.

 

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement herein, or in any subsequently filed document which also is or is deemed to be incorporated by reference, modifies or supersedes such statement.  Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

 

Item 8.  Exhibits. 

 

Exhibit No.   Description
4.1   Composite Copy of the Company’s Articles of Incorporation as amended on July 2, 2020 (incorporated by reference to Exhibit 4.1 of our registration statement on Form S-3 filed on July 16, 2020).
4.2   Amended and Restated By-laws as amended on September 10, 2020 (incorporated by reference to Exhibit 3.3 of our annual report on Form 10-K filed on September 10, 2020).
4.3   Articles of Merger between Pluri Inc. and Pluri Inc. (incorporated by reference to Exhibit 3.1 of our current report on Form 8-K filed on July 25, 2022).
5.1*   Opinion of Sullivan & Worcester LLP.
23.1*   Consent of Sullivan & Worcester LLP (contained in the opinion of Sullivan & Worcester LLP filed herewith as Exhibit 5.1).
23.2*   Consent of Kesselman & Kesselman, Independent Registered Public Accounting Firm.
24.1*   Powers of Attorney (included in the signature page to this registration statement).
99.1   The Company’s 2016 Equity Compensation Plan (incorporated by reference from the Company’s definitive proxy statement on Schedule 14A filed with the Commission on April 4, 2016).
107*   Filing Fee Table

 

*Filed herewith.

 

II-1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Haifa, Israel, on February 13, 2023.

 

  PLURI INC.

 

  By: /s/ Yaky Yanay
    Yaky Yanay
    Chief Executive Officer

 

POWER OF ATTORNEY AND SIGNATURES

 

We, the undersigned officers and directors of Pluri Inc., hereby constitute and appoint Yaky Yanay and Chen Franco-Yehuda and each of them singly, our true and lawful attorneys-in-fact, with full power to them in any and all capacities, to sign any and all amendments to this registration statement on Form S-8 (including any post-effective amendments thereto), and to file the same, with exhibits thereto and other documents in connection therewith, with the Commission, hereby ratifying and confirming all that each of said attorneys-in-fact may do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ Yaky Yanay   Chief Executive Officer, President and Director   February 13, 2023
Yaky Yanay   (Principal Executive Officer)    
         
/s/ Chen Franco-Yehuda   Chief Financial Officer and   February 13, 2023
Chen Franco-Yehuda   (Principal Financial and Accounting Officer)    
         
/s/ Zami Aberman   Chairman of the Board of Directors   February 13, 2023
Zami Aberman        
         
/s/ Doron Birger   Director   February 13, 2023
Doron Birger        
         
/s/ Rami Levi   Director   February 13, 2023
Rami Levi        
         
/s/ Prof. Varda Shalev   Director   February 13, 2023
Prof. Varda Shalev        
         
/s/ Maital Shemesh-Rasmussen   Director   February 13, 2023
Maital Shemesh-Rasmussen        

 

 

II-2

 

 

 

Pluristem Therapeutics (NASDAQ:PSTI)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Pluristem Therapeutics Charts.
Pluristem Therapeutics (NASDAQ:PSTI)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Pluristem Therapeutics Charts.